CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-05 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +44,466 | 44,466 | ||
| 2021-10-05 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +47,335 | 47,335 | ||
| 2021-10-05 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +44,753 | 44,753 | ||
| 2021-10-05 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +34,425 | 34,425 | ||
| 2021-07-06 | TRENARY C RUSSELL III CEO and President | Grant or award · Stock Option (Right to Buy) | +4,000,000 | 4,000,000 | ||
| 2021-04-20 | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | Purchase | +10,000 | $1.83 | $18K | 18,926 |
| 2021-04-19 | Haddadin Yezan Munther Director | Purchase | +10,000 | $1.82 | $18K | 20,000 |
| 2021-04-19 | Sukhtian Faisal Ghiath Director | Purchase | +10,000 | $1.82 | $18K | 20,000 |
| 2021-03-24 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-03-24 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +20,873 | 20,873 | ||
| 2021-02-23 | Evanson Jeff Chief Commercial Officer | Sale | −8,554 | $2.09 | $18K | 1,141,930 |
| 2021-02-23 | Dagnon Terry Chief Operating Officer | Sale | −15,900 | $2.09 | $33K | 1,127,857 |
| 2021-02-12 | Evanson Jeff Chief Commercial Officer | Sale | −56,973 | $2.55 | $145K | 1,150,484 |
| 2021-02-12 | Dagnon Terry Chief Operating Officer | Sale | −63,700 | $2.55 | $162K | 1,143,757 |
| 2021-02-10 | Sukhtian Ghiath M. Director | Grant or award | +1,013,627 | $1.00 | $1.0M | 11,834,257 |
Page 9 of 14 · 276 trades